Medical
BioNTech’s £1 Billion UK Investment
BioNTech has announced a significant investment of up to £1 billion over the next decade in the UK, establishing research...
Read moreDetailsUK Clinical Trials Revolution: Faster Approvals by 2026
The UK is set to revolutionize its clinical trials system by April 2026, promising faster approvals and more inclusive research....
Read moreDetailsNHS Dental Contract Reform Survey
A new nationwide survey invites dental practices across England to share insights on the costs and pressures of running NHS...
Read moreDetailsMental Health Support 900K Pupil Expansion
Almost one million more pupils in England will gain access to mental health support in schools this year, expanding coverage...
Read moreDetailsNHS Leadership Pay Reform
NHS leaders in England are set to experience a significant shift in their pay structure, with performance-based incentives and penalties...
Read moreDetailsInfected Blood Scandal: UK’s £11.8 Billion Compensation Commitment
The UK government has committed £11.8 billion to one of the most comprehensive compensation schemes in history for victims of...
Read moreDetailsMen’s Health Strategy Launch: Tackling Disparities
On May 13, 2025, Health and Social Care Secretary Wes Streeting announced the launch of England’s first Men’s Health Strategy...
Read moreDetailsDigital Mental Health Collaboration: UK Safety Initiative
Two women with lived experience of mental health challenges are collaborating to ensure digital mental health technologies (DMHTs) in the...
Read moreDetailsADZYNMA Approval: Breakthrough Treatment for cTTP
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved ADZYNMA, the first treatment for congenital thrombotic thrombocytopenic purpura...
Read moreDetailsCombatting Synthetic Opioids: UK Government’s New Guidance
The UK government has introduced new guidance to combat the rising threat of synthetic opioids, which have caused over 450...
Read moreDetails